Delivery Order SPE2DB24D2205-SPE2DB24FDULV
- Not listed
- This federal contract award is for the delivery of 4,565,518,871 units of Fexofenadine HCL 180 mg tablets to the Defense Logistics Agency (DLA). The $3,351.60 firm fixed-price delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, a for-profit pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 21, 2024 and was awarded on August 20, 2024. This delivery order is part of a larger $999,999,999 Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Fexofenadine HCL 180 mg tablets to the Defense Logistics Agency (DLA). The firm-fixed-price contract, valued at $3,051.83, has an ultimate completion date of March 28, 2025. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,845.00, is for the delivery of fexofenadine HCl 180 mg tablets. The contract has an ultimate completion date of March 25, 2025 and is a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- This federal contract award is for the delivery of Fexofenadine HCL 180mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This is a firm fixed price delivery order contract with a ceiling value of $2,097.33 and a period of performance through April 2, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,235.74, is a Delivery Order for the supply of Fexofenadine HCL 180 mg Tablets, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fexofenadine HCL 180 mg tablets. The contract is a delivery order with a firm fixed price of $2,696.87 and an ultimate completion date of July 18, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Fexofenadine HCL 180 mg tablets to the Defense Logistics Agency (DLA). The $2,387.19 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award has an ultimate completion date of April 10, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, particularly the Department of Defense...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,821.44, is for the delivery of Fexofenadine HCL 180 mg Tablets. This is a firm fixed-price delivery order contract with a completion date of May 31, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for the delivery of Fexofenadine Hydrochloride 180 mg tablets. The contract has a ceiling value of $1,257.08 and a completion date of June 5, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen holds a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,284.95 delivery order contract is for the supply of Fexofenadine HCL 180 mg tablets and has a period of performance through February 4, 2025. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB24FDULVDelivery Order
This federal contract award is for the delivery of Fexofenadine HCL 180 mg tablets to the Defense Logistics Agency (DLA). The $1,143.67 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 21, 2024, with a completion date of May 22, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 5/21/24 |